Clinical Trial Update: Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/Phase 2 evaluation of the 68Ga-NODAGA-SNA006 PET/CT imaging agent for tumors, with the study currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-NODAGA-SNA006 (NODAGA-SNA006 radiotracer)

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING